Nigeria Adds HPV Vaccine to Save Girls from Cancer

Dr. Aisha Mustapha spent years treating cervical cancer patients before she became one herself. The Nigerian gynecologist caught her cancer at the earliest possible stage and achieved complete cure, but she knows most women never get that chance.

Her story highlights a powerful truth: cervical cancer is almost entirely preventable, yet it kills more than 90% of its victims in low and middle-income countries. In Nigeria, most cases are detected too late because prevention depends on individual awareness rather than strong healthcare systems.

That's changing. In 2023, Nigeria added the HPV vaccine to its routine immunization schedule for girls aged 9 to 14, joining a global effort to eliminate cervical cancer within a generation.

The science is clear and hopeful. HPV types 16 and 18 cause about 70% of cervical cancers worldwide, and safe vaccines have existed for over a decade. When girls get vaccinated before exposure, they gain near-complete protection against these cancer-causing viruses.

The Ripple Effect

Countries that embedded HPV vaccination into school health programs are seeing remarkable results. Rwanda achieved coverage above 90% by treating the vaccine as standard care, backed by clear communication and community engagement. South Africa showed that school-based delivery reaches far more girls than clinic visits, especially in underserved areas.

Nigeria is following this blueprint, but progress varies widely by state. Some regions moved quickly while others struggle with funding, staffing, and coordination between health and education departments. Myths about infertility and promiscuity still affect uptake in some communities.

A recent caregiver survey revealed the gap: fewer than half of parents know the correct age group for vaccination, and only one-third know where to get it. Yet when parents receive clear information, uptake jumps significantly.

The solution is treating HPV vaccination like any other routine childhood vaccine. When schools deliver it as expected, ordinary care rather than a special campaign, more girls get protected and families stop viewing it as controversial.

For women already past vaccination age, early screening with HPV tests or visual inspection catches precancerous changes before they become deadly. Dr. Mustapha's early diagnosis meant she avoided chemotherapy and radiotherapy entirely, achieving 100% cure.

Nigeria's challenge now is turning policy into practice across all 36 states. That means routine financing, trained vaccination teams, reliable vaccine supplies, and publicly tracked coverage data. It means making prevention the norm, not a privilege.

Thousands of Nigerian girls could grow up never fearing cervical cancer if today's systems hold strong.